Obada Al-Zghool

Preclinical development of radiopharmaceuticals for Alzheimer’s disease: Biological evaluation of (S)-[18F]THK5117 and [11C]SMW139 PET tracers in the APP/PS1-21 mouse model of Alzheimer’s disease (2024)

Al-Zghool Obada

(G5 Artikkeliväitöskirja)

α-Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New Perspectives (2022)

Movement Disorders

Obada M. Alzghool, van Dongen Goos, van de Giessen Elsemarike, Schoonmade Linda, Beaino Wissam

(Vertaisarvioitu katsausartikkeli tieteellisessä aikakauslehdessä (A2))

Novel plasma protein binding analysis method for a PET tracer and its radiometabolites: A case study with [11C]SMW139 to explain the high uptake of radiometabolites in mouse brain (2022)

Journal of Pharmaceutical and Biomedical Analysis

Aarnio Richard, Alzghool Obada M, Wahlroos Saara, O'Brien-Brown James, Kassiou Michael, Solin Olof, Rinne Juha O, Forsback Sarita, Haaparanta-Solin Merja

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

(S)-[18F]THK5117 brain uptake is associated with Aβ plaques and MAO-B enzyme in a mouse model of Alzheimer's disease (2021)

Neuropharmacology

Alzghool Obada M, Rokka Johanna, López-Picón Francisco R, Snellman Anniina, Helin Jatta S, Okamura Nobuyuki, Solin Olof, Rinne Juha O, Haaparanta-Solin Merja

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

[18F]F-DPA for the detection of activated microglia in a mouse model of Alzheimer's disease (2018)

Nuclear Medicine and Biology

Keller T, López-Picón FR, Krzyczmonik A, Forsback S, Kirjavainen AK, Takkinen JT, Alzghool O, Rajander J, Teperi S, Cacheux F, Damont A, Dollé F, Rinne JO, Solin O, Haaparanta-Solin M

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Ota yhteyttä

Linkit

Julkaisut

Järjestä:

Preclinical development of radiopharmaceuticals for Alzheimer’s disease: Biological evaluation of (S)-[18F]THK5117 and [11C]SMW139 PET tracers in the APP/PS1-21 mouse model of Alzheimer’s disease (2024)

α-Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New Perspectives (2022)

Novel plasma protein binding analysis method for a PET tracer and its radiometabolites: A case study with [11C]SMW139 to explain the high uptake of radiometabolites in mouse brain (2022)

(S)-[18F]THK5117 brain uptake is associated with Aβ plaques and MAO-B enzyme in a mouse model of Alzheimer's disease (2021)

[18F]F-DPA for the detection of activated microglia in a mouse model of Alzheimer's disease (2018)